Flavopiridol treatment caused a small but highly significant increase in promoter-proximal pausing in an Rtf1-deficient background ( Figure 8a ), with 87.1% of genes with significantly altered PRR values displaying an increase in PRR in flavopiridol-treated rtf1 morphants compared to untreated rtf1 morphants ( Figure 8c ).
1
—
—